CVS Health Corporation
Overview
| Deal Type |
Debt Capital Markets |
|---|---|
| Size |
$3 Billion Junior Subordinated Notes |
| Client & Transactional Partners |
CVS Health Corporation |
| Our Role |
Co-Manager |
Summary
On December 3, 2024, KeyBanc Capital Markets (KBCM) successfully priced $750 million of 6.750% Junior Subordinated Notes due 2054 and $2.25 billion of 7.000% Junior Subordinated Notes due 2055 for CVS Health Corporation (the Company). KBCM acted as Co-Manager on the transaction.
KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.





































